1/24. Zelsuvmi- Berdazimen- (Jan 2024) to treat muscular contration
Drug Name:
1/24. Zelsuvmi- Berdazimen- (Jan 2024) to treat muscular contration
List Of Brands:
Indication Type Description:
Indication:
U.S. FDA APPROVED DRUGS DURING 2024
Sr.No.1/24
Name of the Drug- ZELSUVMI
Active Ingredient - Berdazimen
Pharmacological Classification-
To treat muscular contration
Date of Approval - 1/1/2024
HIGHLIGHTS OF PRESCRIBING INFORMATION